stem cells

Israeli biotechnology company BrainStorm will test its adult stem cells, derived from bone marrow, in 48 ALS patients at three sites

Posted on Friday, June 13, 2014 - 10:06, By: Margaret Wahl
Israeli biotechnology company BrainStorm Cell Therapeutics has enrolled the first participant in a phase 2, U.S.-based trial of adult stem cell transplantation to treat amyotrophic lateral sclerosis (ALS).

Themes discussed at a recent symposium included immune system modulation, combatting toxic proteins and genetic material, replacing or repairing damaged cells, and improving muscle function

Posted on Friday, December 20, 2013 - 10:25, By: Margaret Wahl
"We are undoubtedly slowing down the MND [motor neuron disease] supertanker, and can start to see how we might turn it around for the first tim," said Martin Turner, senior clinician scientist at the University of Oxford (United Kingdom), on research being reported on at the 24th International...

Three short items about the state of ALS science: BrainStorm’s upcoming US stem-cell trial; modifying ALS progression; a blood-based biomarker test

Posted on Wednesday, October 9, 2013 - 05:00, By: Amy Madsen
This roundup of recent amyotrophic lateral sclerosis (ALS) research and clinical trials news includes:

Five short items about the state of ALS science addressing: a therapy targeting SOD1; roles for TDP43 in behavior and body fat; respiratory care; and more

Posted on Tuesday, September 24, 2013 - 14:45, By: Amy Madsen
This roundup of recent amyotrophic lateral sclerosis (ALS) research and clinical trials news includes:

Six short items about the state of ALS science: Neuralstem and Cytokinetics ALS clinical trials; weight maintenance in ALS; stem cell technology; and more

Posted on Thursday, September 12, 2013 - 05:00, By: Amy Madsen
This roundup of recent amyotrophic lateral sclerosis (ALS) research and clinical trials news includes:

10 short items about the state of ALS science, including stem cells; trials and research models; risk factors; SOD1, TDP43 and C9ORF72 ALS-causing mutations; and more

Posted on Thursday, August 15, 2013 - 04:00, By: Amy Madsen
This roundup of recent amyotrophic lateral sclerosis (ALS) research and clinical trials news includes:

Using stem-cell-based drug discovery, potential therapies — such as the molecule kenpaullone — can be tested on human ALS-affected cells before advancing to clinical trials

Posted on Friday, June 21, 2013 - 05:00, By: Amy Madsen
Using a stem-cell-based screening method, a team of researchers based at institutions in Massachusetts and Connecticut identified a small molecule called kenpaullone as a potential therapy for amyotrophic lateral sclerosis (ALS). Further studies revealed that the molecule appears to work by...

Advertisements

myMuscleTeam